Cogent Biosciences (COGT) Shares Outstanding (2017 - 2026)

Cogent Biosciences (COGT) has 9 years of Shares Outstanding (Entity) data on file, last reported at $170.8 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 49.99% year-over-year to $170.8 million in Q1 2026; TTM through Mar 2026 was $170.8 million, a 49.99% increase from a year earlier, with the FY2025 full-year figure at $128.9 million, up 16.69% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $170.8 million, up from $128.9 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for COGT reached as high as $170.8 million in Q1 2026 and fell as low as $45.8 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $97.5 million across 5 years, with a median of $95.6 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) surged 75.3% in 2022 and climbed 4.19% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $69.9 million in 2022, then gained by 23.22% to $86.1 million in 2023, then rose by 28.26% to $110.5 million in 2024, then gained by 16.69% to $128.9 million in 2025, then soared by 32.49% to $170.8 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $170.8 million in Q1 2026, $128.9 million in Q4 2025, and $139.8 million in Q3 2025.